Johnson Matthey’s (JMAT) “Buy” Rating Reaffirmed at Liberum Capital

Liberum Capital reaffirmed their buy rating on shares of Johnson Matthey (LON:JMAT) in a research note issued to investors on Wednesday morning.

A number of other analysts also recently issued reports on JMAT. Citigroup reissued a buy rating on shares of Johnson Matthey in a research report on Tuesday, May 29th. Deutsche Bank reissued a buy rating on shares of Johnson Matthey in a research report on Friday, June 1st. Deutsche Bank reissued a buy rating on shares of Johnson Matthey in a research report on Friday, June 1st. Morgan Stanley reissued an overweight rating and issued a GBX 3,900 ($50.80) target price on shares of Johnson Matthey in a research report on Monday, June 4th. Finally, Berenberg Bank reissued a buy rating and issued a GBX 4,300 ($56.01) target price on shares of Johnson Matthey in a research report on Tuesday, July 3rd. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The stock has a consensus rating of Buy and an average price target of GBX 3,962.50 ($51.62).

LON:JMAT opened at GBX 3,555 ($46.31) on Wednesday. Johnson Matthey has a 1 year low of GBX 2,681 ($34.92) and a 1 year high of GBX 3,511 ($45.73).

In related news, insider Robert MacLeod purchased 12 shares of Johnson Matthey stock in a transaction dated Wednesday, July 18th. The stock was bought at an average cost of GBX 3,722 ($48.48) per share, for a total transaction of £446.64 ($581.79). Also, insider Annette Kelleher sold 985 shares of Johnson Matthey stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of GBX 3,709 ($48.31), for a total value of £36,533.65 ($47,588.45). Over the last quarter, insiders bought 36 shares of company stock valued at $130,944.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Story: Investing in Dividend Stocks

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply